Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cyclophosphamide (cytoxan) (1 trial)
fludarabine (fludara) (1 trial)
rituximab (rituxan) (1 trial)
Lymphoma (Phase 4)
Lymphoma, Non-Hodgkin (Phase 4)
Trials (1 total)
Trial APIs (3 total)